Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma

Author： Hoy Sheridan M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.14, 2012-10, pp. : 1929-1950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Plosker G.L.   Figgitt D.P.  

Drugs, Vol. 63, Iss. 8, 2003-01 ,pp. : 803-843

Adis International

Access to resources Recommend Favorite

Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Cvetković Risto S.   Perry Caroline M.  

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 791-820

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Indolent Non-Hodgkin Lymphoma

By Plosker Greg L.   Carter Natalie J.  

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2645-2660

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

By Garnock-Jones Karly P.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1703-1718

Adis International

Access to resources Recommend Favorite

Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Hagemeister Fredrick  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 261-272

Adis International

Access to resources Recommend Favorite